Companies: 10,795·Total market cap: $144.5T
BioSyent Inc.

BioSyent Inc.

BIOYFOTCHealthcare● Active
$9.97
+$0.16(+1.63%)
Market Cap$114040030
P/E Ratio
52W High$12
52W Low$7.63

BioSyent Inc. (BIOYF) Revenue

Annual & quarterly revenue history · segment & region breakdown

BIOYF · revenue · updated Jun 9, 2026

Core revenue metrics

BioSyent Inc. trailing twelve-month (TTM) revenue is $0.05B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.05B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
2.48×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$767K
60 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · BioSyent Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BIOYF revenue by year · BIOYF revenue history · BIOYF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income BioSyent Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

BioSyent Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from BioSyent Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BIOYF revenue · 4 questions

BIOYF's trailing twelve-month (TTM) revenue is $0.05B. That is an increase of 0.00% year-over-year from — in FY.

BIOYF revenueBIOYF annual revenuewhat is BIOYF revenueBIOYF TTM revenue

Source: FMP · BioSyent Inc. SEC filings · GAAP · BioSyent Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026